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Abstract
Objective To evaluate the morphological changes of the
parotid glands in patients treated with intensity-modulated
radiotherapy (IMRT) for nasopharyngeal and oropharyn-
geal tumors and the correlations with parotid function.
Methods Ten patients with nasopharyngeal and oropha-
ryngeal tumors treated with IMRT between May 2009 and
January 2010 at Hokkaido University Hospital were
included in this study. In the morphological assessment of
the parotid glands, the sizes and computed tomography
(CT) numbers of the bilateral parotid glands before and
after IMRT with CT were calculated. For functional
assessment of the parotid glands, we conducted the Saxon
test and used a visual analog scale (VAS) for xerostomia
evaluation.
Results Reductions in saliva secretion were observed in
the patients treated with IMRT for nasopharyngeal and
oropharyngeal tumors, and there was a significant
correlation between the reduction in saliva secretion and
the VAS. The reductions in the parotid gland size and CT
number were larger on the ipsilateral side than on the
contralateral side. The reduction in saliva secretion was not
significantly correlated with the reduction in parotid gland
size, but was significantly correlated with the reduction in
CT number.
Conclusions Morphological and functional changes of
the parotid glands were observed after IMRT for naso-
pharyngeal and oropharyngeal tumors, and preservation of
the contralateral parotid glands was only partly achieved.
Among the morphological changes of the parotid glands,
the CT number may be considered a predictor of parotid
function after radiotherapy.
Keywords Intensity-modulated radiotherapy
(IMRT)  Parotid gland  Nasopharyngeal and
oropharyngeal tumors  Morphological and functional
changes
Introduction
Radiotherapy plays an important role in head and neck
tumor treatment because of the cosmetic and functional
preservation that becomes possible. Despite advances in
radiotherapy equipment and irradiation technology, mor-
bidity related to radiotherapy is not completely avoidable
[1]. Xerostomia is a common adverse effect of radio-
therapy for head and neck tumors, and results in reduced
patient quality of life by inducing dysphagia, dysgeusia,
caries, and periodontitis [2]. In recent years, our hospital
has used intensity-modulated radiotherapy (IMRT) for
patients with head and neck tumors to enable preservation
of the major salivary glands. It has been reported that
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IMRT is superior to conventional radiotherapy in regard
to dose, dosimetry, and preservation of salivary gland
functions [3, 4]. However, we have experienced a variety
of subjective complaints of xerostomia in patients treated
with IMRT. The present study aimed to evaluate the
morphological changes of the parotid glands in patients
treated with IMRT for nasopharyngeal and oropharyngeal
tumors and to assess the correlations with the functioning
of the parotid glands.
Patients and methods
Patient characteristics
Between April 2009 and January 2010, six patients with
nasopharyngeal tumors and four patients with oropha-
ryngeal tumors were treated with IMRT at the Division of
Radiotherapy, Hokkaido University Hospital. Written
informed consent for IMRT was obtained from all
patients. Histologically, one patient with tonsil lesions
was diagnosed with non-Hodgkin’s lymphoma, and six
patients with nasopharyngeal tumors and three patients
with oropharyngeal tumors were diagnosed with squa-
mous cell carcinomas. The patients were six males and
four females (mean age 64 years, age range 40–85 years).
Clinically, the tumors were diagnosed as T1 in two
patients, T2 in four, and T3 in four, and the nodal
involvement was N0 in three patients, N1 in one, N2a in
two, and N2b in four (Table 1). Seven of the ten patients
received concurrent chemotherapy consisting of CDDP
(cisplatin) (six patients) and TPF (taxotere ? cisplatin ?
5-fluorouracil) (one patient).
Parotid sizes and computed tomography (CT) numbers
The sizes and CT numbers of the bilateral parotid glands
were determined on axial plain CT images before and after
IMRT. Cross-sectional long/short diameters, showing the
maximum area of the parotid glands, were also measured.
The axial scan that showed the fewest artifacts caused by
metal restorations and crowns in the oral cavity and had the
largest size was selected to calculate the CT numbers of the
parotid glands. The posterolateral regions of the parotid
glands avoiding the retro-mandibular veins were selected
to calculate the CT numbers. The CT numbers were
determined three times, and the mean CT number was used
as the representative CT number for a parotid gland
(Fig. 1a, b).
Saxon test and visual analog scale (VAS)
As an objective assessment of salivation, we conducted the
Saxon test before and after IMRT. The Saxon test was
performed in the morning at our outpatient clinic. Patients
were instructed not to drink, eat, or smoke for 2 h before
the examination. In the Saxon test, saliva production was
measured by weighing gauze before and after 2 min of
chewing without swallowing. As a subjective assessment
of salivation, we applied a VAS for xerostomia. The VAS
was a horizontal 100-mm line with vertical anchoring lines.
The description used at the left end (0 mm) was ‘‘No
feeling of dry mouth’’ and that at the right end (100 mm)
was ‘‘Feeling dry mouth as severe as it can be’’. The CT
examination, Saxon test, and VAS were performed within
1 week before the start of IMRT and after the completion
of IMRT in each patient.
Statistical analysis
The changes in the bilateral parotid sizes and CT numbers
before and after IMRT were compared with the Saxon test
and VAS. Differences between the parotid glands on the
ipsilateral side and the contralateral side were compared
with a Student’s t-test. The relationship between the parotid
morphological and functional changes was evaluated with
a Spearman rank correlation test. Statistical analyses were
carried out using StatView Version 5 (SPSS, Cary, NC).
Table 1 Patient and tumor
characteristics
NP nasopharynx, OP
oropharynx, p posterior,
u upper, rt right, lt left, SCC
squamous cell carcinoma, ML
malignant lymphoma; TPF
taxotere ? cisplatin ? 5-
fluorouracil, CDDP cisplatin
Patient no. Age/sex Primary site TNM Pathology Chemotherapy
1 59/F NP (p-lt wall) T2N2bM0 SCC TPF
2 68/M OP (rt tonsil) T3N0M0 SCC CDDP
3 73/M OP (rt tonsil) T3N2bM0 ML
4 45/F NP (rt wall) T2N2M0 SCC CDDP
5 66/F NP (rt wall) T1N0M0 SCC CDDP
6 71/F OP (rt tonsil) T2N2bM0 SCC CDDP
7 40/M NP (rt wall) T3N1M0 SCC CDDP
8 77/M NP (lt wall) T1N2M0 SCC
9 56/M OP (lt tonsil) T2N2bM0 SCC CDDP
10 85/M NP (u-p wall) T3N0M0 SCC
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Values of p\ 0.05 were considered to indicate statistical
significance.
Results
The total dose to planning target volume (PTV) was 70 Gy
in 35 fractions for squamous cell carcinomas and 50 Gy in
25 fractions for malignant lymphomas. The ipsilateral
parotid glands were partially included in the PTV (Fig. 2).
The mean dose was 41.5 Gy (33.9–68.4 Gy) for the
ipsilateral parotid glands and 31.7 Gy (26.0–43.5 Gy) for
the contralateral parotid glands. The average saliva secre-
tion was 6.1 g (0.7–21.7 g) before IMRT and 1.4 g
(0.3–4.1 g) after IMRT, giving a reduction rate of 69.5 %
(0–90.0 %). For the subjective assessment of xerostomia,
the VAS varied depending on the patients, and the mean
score was 6.6 (2–10) (Table 2). There was no correlation
between the total dose to the bilateral parotid glands and
the reduction in salivation (r = 0.26) (Fig. 3). There was a
significant correlation between the reduction in salivation
and the VAS (r = 0.64, p\ 0.05) (Fig. 4). The rate of
Fig. 1 a Method for determining the sizes of the parotid glands.
Cross-sectional long/short diameters, showing the maximum area of
the parotid glands, were measured on axial plain CT images.
b Method for determining the CT numbers of the parotid glands.
Circular regions of interest were selected on the posterolateral
regions of the parotid glands, avoiding the retro-mandibular veins
Fig. 2 Dose distribution and dose-volume histogram for a patient with an oropharyngeal tumor
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reduction in the parotid gland size was 39.4 %
(23.8–50.7 %) for the ipsilateral side and 26.5 %
(12.9–44.9) for the contralateral side, and the difference
was significant (p\ 0.02) (Fig. 5). No significant correla-
tion was established between the bilateral reduction in the
parotid size and salivation (r = 0.32) (Fig. 6). The CT
number was reduced by 13.8 (-28.8 to ?17.0) for the
ipsilateral side and 5.4 (-14.8 to ?14.3) for the contra-
lateral side, and the difference was significant (p\ 0.05)
(Fig. 7). There was a significant strong correlation between
the reductions in the CT number and salivation (r = 0.84,
p\ 0.01) (Fig. 8). It was observed that the CT numbers of
the parotid glands tend to revert after completion of IMRT
(Figs. 5, 7).
Discussion
IMRT is a newly introduced technique that aims to spare
radiosensitive organs while delivering adequate doses to
tumors. Initially, prostate cancer was treated with IMRT to
Table 2 Doses to PTV and bilateral parotid glands, saliva secretion,
and VAS
Patients Total
dose
(Gy/
fractions)
Parotid
mean
dose
(Gy)
(ipsi/
cont)
Pre-
RT (g/
2 min)
Post-
RT (g/
2 min)
Reduction
rate (%)
VAS
1 70/35 39.1/28.3 0.7 0.7 0 3
2 70/35 38.5/29.0 7.5 4.1 45.3 6
3* 50/25 38.0/26.5 4.4 0.6 86.4 8
4 70/35 58.8/43.5 8.9 1.5 83.1 10
5 70/35 38.7/35.5 5.0 0.5 90.0 9
6# 70/35 68.4/32.1 4.6 1.1 76.1 3
7 70/35 37.6/33.5 4.1 0.6 85.2 9
8 70/35 33.9/33.5 3.7 0.5 86.5 5
9 70/35 36.4/29.3 21.7 3.9 82.3 7
10 70/35 26.0/25.9 0.9 0.3 60.0 6
Mean 41.5/31.7 6.1 1.4 69.5 6.6
ipsi Ipsilateral, cont contralateral, RT radiotherapy, VAS visual analog
scale
* A case of malignant lymphoma
# Lymph node metastasis in the ipsilateral parotid gland
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Fig. 3 Relationship between the total dose to the bilateral parotid
glands and the reduction in salivation. The Spearman rank correlation
coefficient is 0.26
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Fig. 4 Relationship between the reduction in salivation and the VAS.
The Spearman rank correlation coefficient is 0.64 (p\ 0.05)
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Fig. 5 Comparison of the rate of the size reduction between the
ipsilateral and contralateral parotid glands. The difference is signif-
icant (p\ 0.02, Student’s t-test). RT radiotherapy, W week
138 Oral Radiol (2014) 30:135–141
123
prevent adverse effects on the rectum [5]. Many patients
treated with radiotherapy for head and neck malignancies
suffer from xerostomia, which causes reductions of patient
quality of life, including difficulty of speaking and swal-
lowing, as well as taste loss and oral infections [2]. There
have been several attempts to reduce radiation damage to
the major salivary glands in radiotherapy [3, 4]. In this
study, IMRT was applied to preserve the functions of the
salivary glands. In most IMRT studies, much effort goes
into reducing the parotid gland dose. A number of papers
have reported theoretical values for acceptable IMRT doses
in the reduction of parotid gland doses [6]. However, only a
few reports have dealt with measurements to assess the
effects of reducing the gland doses. Marks et al. [7]
observed a marked reduction in salivary flows in glands
receiving more than 30–40 Gy. Leslie and Dische [8]
found that the average parotid salivary flow was 60–70 %
of the baseline following 10–14 Gy and undetectable in
glands receiving 40–42 Gy [8]. They concluded that the
dose required for an optimum effect lies between 15 and
40 Gy. In the present study, we used the Saxon test to
measure the saliva output, because it reflects the function
of the parotid glands as stimulated salivation rather than
unstimulated salivation, which is predominantly from the
submandibular glands. The mean dose to the parotid gland
for the ipsilateral and contralateral parotid glands was
41.5 Gy and 31.7 Gy, with size reductions of 39.4 and
26.5 %, respectively (p\ 0.02). Although the saliva flow
from each parotid gland was not separately determined, this
result may still reflect a dose-dependent morbidity of the
parotid gland function, and the threshold beyond which
damage becomes prominent may lie around 30 Gy. The
saliva reduction rate in this study was 69.5 %, which is
comparable to other studies. Although feelings of mouth
dryness are very subjective and affected by variability, the
present measurements showed significant correlations
between the objective saliva output and the Saxon test and
VAS. These results indicate that the VAS, reflecting the
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Fig. 6 Relationship between the reduction in the parotid size and
salivation. The Spearman rank correlation coefficient is 0.32
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Fig. 7 Comparison of the reduction in the CT numbers between the
ipsilateral and contralateral parotid glands. The difference is signif-
icant (p\ 0.05, Student’s t-test). RT radiotherapy, W week
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Fig. 8 Relationship between the reduction in the CT numbers and
salivation. The Spearman rank correlation coefficient is 0.84
(p\ 0.01)
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subjective patient sensation of mouth dryness, is a useful
and concise parameter to assess xerostomia after radio-
therapy. Teshima et al. [9] evaluated the correlation
between parotid volume and saliva production in patients
treated with preoperative radiotherapy for oral cancers.
They reported that after 30 Gy of irradiation, the mean
saliva production decreased from 4.2 to 1.0 g and the post-
radiotherapy/pre-radiotherapy parotid volume ratio ranged
from 54 to 85 % (mean 71 %) [9]. They also indicated that
the post-radiotherapy/pre-radiotherapy parotid volume
ratio was inversely and significantly correlated with the
amount of post-radiotherapy saliva reduction [9]. The
reduction in the parotid gland size in the present study was
39.4 % for the ipsilateral side and 26.5 % for the contra-
lateral side. These findings may demonstrate that IMRT
achieved the aim of alleviating the adverse effects on the
contralateral parotid glands, taking into consideration the
fact that almost all patients in this study were administered
70 Gy of irradiation and that the difficulties in IMRT
planning because of the reduced laterality resulted from the
tumor staging and occurrence site. Although there was no
significant correlation between the reduction in the parotid
gland sizes and saliva production, this is likely to arise
from the small sample size in this study. There have been
no other reports of CT numbers of salivary glands after
radiotherapy. Heo et al. [10] reported a quantitative anal-
ysis of normal major salivary glands using CT, and
reported that the CT numbers varied widely with sex, age,
and obesity state (body mass index). Similar to the previous
reports, the CT numbers of the patients in the present study
varied from -69.7 to ?15.0. A reduction in the CT number
was observed in 9 of the 10 patients in this study, and the
range of the reduction was significantly larger in the ipsi-
lateral parotid gland than in the contralateral parotid gland
(p\ 0.05). Numerous investigators have described the
nature of salivary gland damage after irradiation in animal
studies [10–13]. The irradiated parotid glands are charac-
terized by significant fibrosis, acinar atrophy, and paren-
chymal loss [10, 11]. It is known that radiation-induced
fatty replacement of bone marrow is the most common
osseous abnormality observed in patients with doses as low
as 800 cGy [14]. Furthermore, Tartaglino et al. [15]
reported that muscle and salivary gland atrophy with fatty
replacement may arise from radiation-induced changes in
the head and neck. Sagowski et al. [13] reported that pro-
gressive vacuolization (30 Gy) developed into lipomatosis
(46 Gy) in rat parotid glands. The reductions in the CT
numbers after radiotherapy in the present study may have
resulted from acinar atrophy, parenchymal loss, and fatty
replacement, which would be in agreement with the pre-
vious reports. On the contrary, another report demonstrated
increased attenuation and enhancement as well as atrophy
of salivary glands after radiotherapy evaluated by contrast-
enhanced CT [14]. The enhancements of the salivary
glands may be caused by contrast material leakage owing
to increased vascular permeability or an increase in the
extracellular space owing to a diminished number of acini
[14]. Although the CT scans obtained in the present study
were plain (non-enhanced), one patient showed an increase
in the CT number. This patient complained of parotid
tenderness after the radiotherapy, and may have been
affected by sialadenitis. This could be a result of increases
in water content caused by edema of the inflamed parotid
gland. Nomayr et al. [16] reported that after irradiation of
70 Gy, salivary gland edema, corresponding to sialadenitis,
was detected in 2 of 9 cases (parotid gland) and 4 of 13
cases (submandibular gland). The present study may pro-
vide additional insight into the effects of radiation-induced
salivary gland injury. Among the morphological changes of
the parotid glands, the CT number can also be a predictor
of the function of saliva production after radiotherapy.
Further studies of this matter are necessary, including
attention to the morphological changes of submandibular/
sublingual glands with longer follow-up periods and
comparisons of IMRT with conventional RT.
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